Description
Product Description
Metacardia MR 35 mg 30 Modified-Release Tablets contains Trimetazidine, used to improve myocardial energy metabolism and reduce symptoms of stable angina by enhancing cardiac efficiency.
Active Ingredient
Trimetazidine 35 mg (Modified Release).
Indications
Treatment of stable angina pectoris
Improvement of cardiac performance
Reduction of ischemic symptoms
Support for exercise tolerance in cardiac patients
Warnings
Use under medical supervision
May cause dizziness or mild gastrointestinal upset
Use with caution in elderly patients
Do not stop treatment abruptly
Keep out of reach of children
Reviews
There are no reviews yet.